Literature DB >> 20980958

Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D.

Ruzena Tkacova1, Annette McWilliams, Stephen Lam, Don D Sin.   

Abstract

BACKGROUND: Surfactant protein D (SP-D) is a promising blood biomarker in patients with chronic obstructive pulmonary disease (COPD). Nevertheless, circulating levels of SP-D are not related to pulmonary functions. In the present exploratory study, we created a simple index of plasma to bronchoalveolar lavage (BAL) fluid ratio of SP-D (pSP-D/bSP-D), and determined whether this index would relate to the severity of airflow limitation and hence represent a superior biomarker than pSP-D alone. MATERIAL/
METHODS: In 50 ex and current smokers (mean age 57.6±7.8 years, 74% men), SP-D was measured in BAL fluid and plasma samples, and the relationships between spirometric variables and a composite parameter - the pSP-D/bSP-D ratio were determined.
RESULTS: There was a significant inverse correlation between the pSP-D/bSP-D ratio and the severity of airflow obstruction, as measured by FEV1/FVC (p=0.012). In contrast, no relationship was observed between FEV1/FVC and pSP-D alone.
CONCLUSIONS: We suggest that integrating both lung and plasma expression of pneumo-proteins may be more useful than plasma expression alone in developing pneumo-proteins as potential biomarkers in COPD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980958

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  7 in total

1.  Involvement of surfactant protein D in emphysema revealed by genetic association study.

Authors:  Takeo Ishii; Koichi Hagiwara; Koichiro Kamio; Shinobu Ikeda; Tomio Arai; Makiko Naka Mieno; Toshio Kumasaka; Masaaki Muramatsu; Motoji Sawabe; Akihiko Gemma; Kozui Kida
Journal:  Eur J Hum Genet       Date:  2011-09-21       Impact factor: 4.246

Review 2.  Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.

Authors:  Ho Il Yoon; Don D Sin
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

3.  Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.

Authors:  Carla Winkler; Elena N Atochina-Vasserman; Olaf Holz; Michael F Beers; Veit J Erpenbeck; Norbert Krug; Stefan Roepcke; Gereon Lauer; Martin Elmlinger; Jens M Hohlfeld
Journal:  Respir Res       Date:  2011-03-11

4.  Factors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.

Authors:  Preston E Bratcher; Amit Gaggar
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

5.  Serum Uric Acid Levels and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Parameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease?

Authors:  Nagihan Durmus Kocak; Gulsah Sasak; Ulku Aka Akturk; Metin Akgun; Sibel Boga; Aysun Sengul; Sinem Gungor; Sibel Arinc
Journal:  Med Sci Monit       Date:  2016-11-03

6.  Association of IREB2 Gene rs2568494 Polymorphism with Risk of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.

Authors:  Yiming Du; Yuwen Xue; Wei Xiao
Journal:  Med Sci Monit       Date:  2016-01-18

Review 7.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.